AusCann Group Holdings has announced changes to its board as it progresses towards the next stage of growth and development as a cannabinoid-focused pharmaceutical company.
AusCann Group Holdings chair Mal Washer and director Cheryl Edwardes have advised they will retire from the medical cannabis company's board, with major shareholder Merchant Group planning to nominate one new director.
Medical cannabis company AusCann Group Holdings has appointed international pharmaceutical executive Ido Kanyon as its new chief executive, nearly five months after it was announced that Elaine Darby would resign from the role.
AusCann Group Holdings has today announced two board changes, with managing director Elaine Darby advising of her resignation and pharmaceutical executive Paul MacLeman appointed as executive director.
SPECIAL REPORT: AusCann has benefited from a wave of interest in medicinal cannabis for pain relief to be the BN30's top performer in shareholder returns for the year to June 30.
Altura Mining directors Allan Buckler and Paul Mantell and AusCann Holdings directors Mal Washer and Harry Karelis have been among a group of major Western Australian investors to have the value of their portfolios hit as markets have fluctuated in recent weeks.
A medical cannabis company focused on animal health has announced plans to list on the ASX, while two other companies - including a pearling business - have made movements in the pharmaceutical space.
The directors of medicinal cannabis companies Creso Pharma and AusCann Group Holdings have reaped windfall gains worth $13 million after the vesting of performance rights and performance shares.
Perth company AusCann Group Holdings has become the seventh applicant to gain regulatory approval to cultivate medicinal cannabis in Australia, with the news lifting its share price by 17 per cent today.
Murdoch University has partnered with a Perth company which plans to use cannabis as a medicinal product, a day after scientists from the University of Western Australia said cannabis use could damage a person's DNA.
Shares in TW Holdings slumped sharply today after it announced a backdoor listing of medical cannabis company AusCann Group Holdings, the second deal of this type involving members of the Washer family.
